MedElevator Войти в исследования
← Поиск публикаций

DOI 10.6002/ect.mesot2025.o56

Медицинская библиотека · Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation · 2026

Monoclonal Gammopathies in Kidney Transplant Recipients: A Retrospective Analysis of Incidence, Clinical Characteristics, and Outcomes.

Ghenam Nehed, Ben Aycha Narjess, Boukadida Raja, Thabet Nessrine, Azzabi Awatef, Guedri Yosra, Ben Sayed Nesrine, Abdessayed Nihed, Sahtout Wissal, Zellama Dorsaf

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

Monoclonal gammopathies represent a spectrum of clinical and biological abnormalities characterized by monoclonal immunoglobulin production from plasma cell clones. In kidney transplant recipients, monoclonal gammopathies and their identification constitute a complex and multifactorial phenomenon involving immunological alterations and underlying pathologies such as multiple myeloma or lymphoproliferative diseases.

MATERIALS AND

METHODS

We retrospectively studied patients who underwent kidney transplant at the Nephrology Department of Sahloul University Hospital from November 1, 2007, to December 31, 2024, and who had detection of monoclonal gammopathies during follow -up.

RESULTS

Among 332 kidney transplant recipients, 10 (3.0 % ) developed monoclonal gammopathies. Mean age was 42.4 years (range, 27 -58 years ), with male predominance (70 % ). Hypertension was the most frequent comorbidity (50 % ). Only 1 patient had preexisting monoclonal gammopathies before transplant. Chronic interstitial nephropathy was the most common initial nephropathy (62.5 % ). Mean time to diagnosis of monoclonal gammopathies posttransplant was 58.9 months. Serum protein electrophoresis revealed monoclonal peaks in the gamma -globulin region (70 % ), beta -1 globulin (20 % ), and beta -2 globulin (10 % ). Immunofixation showed immunoglobulin G lambda (40 % ), immunoglobulin G kappa, immunoglobulin A lambda and kappa, and isolated light chains. Proteinuria was present in 60 % and anemia in 70 % of cases. Evolution included return to hemodialysis in 3 patients, infectious complications in 4 patients, and 1 death.

CONCLUSIONS

The effect of monoclonal gammopathies on kidney transplant recipients remains an evolving research domain where diagnostic and therapeutic advances play a key role in improving management of these vulnerable patients.

Для цитирования: Ghenam Nehed, Ben Aycha Narjess, Boukadida Raja, Thabet Nessrine, Azzabi Awatef, Guedri Yosra, Ben Sayed Nesrine, Abdessayed Nihed, Sahtout Wissal, Zellama Dorsaf. Monoclonal Gammopathies in Kidney Transplant Recipients: A Retrospective Analysis of Incidence, Clinical Characteristics, and Outcomes.. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 2026. DOI: 10.6002/ect.mesot2025.o56.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.